The bill before us, of course, is the reauthorization of the Food and Drug Administration, several important parts of the Food and Drug Administration, and a new section on drug safety to give the Food and Drug Administration a few more tools for their tool box. Most Americans who turn to imported drugs do so because of the cost. We need to answer a lot of questions before we open our borders to imported drugs to be sure we don't endanger consumers or jeopardize research or jeopardize the development of new lifesaving products. I don't think there is anybody in this Chamber who couldn't agree more with that statement, but I am sure they would agree that a counterfeit or tainted drug is unsafe at any price. As we consider the issue of drug importation, the safety of our citizens must be our primary concern.
Mike Enzi: “The bill before us, of course, is the reauthorization of the Food and Drug Administration, several important parts of…”
Editor's note · Context
Discussing the reauthorization of the Food and Drug Administration and drug safety.
Share
More from Mike Enzi
I rise to raise a point of order on the Further Consolidated Appropriations Act of 2020, which provides funding for eight appropriations subcommittees and includes numerous tax and healthcare provisions and other new legislation called…
I rise today to discuss our Federal finances and the need to address our unsustainable fiscal debt and deficit. The Federal budget has already been on an unsustainable path before COVID-19 reached our shores and before the pandemic and our…
I ask unanimous consent that Dan Flavin, a Government Accountability Office detailee on the Budget Committee, be granted floor privileges for the remainder of the Congress. The PRESIDING OFFICER. Without objection, it is so ordered…
the Bipartisan Budget Act of 20l9, P.L. 116- 37, included an instruction to the chairman of the Senate Committee on the Budget to file allocations, aggregates, and budgetary levels in the Senate between April 15, 2020, and May 15, 2020…





